Trial Profile
A study of efficacy and tolerability of ivacaftor in patients with cystic fibrosis (CF) with the G551D mutation in a single clinical unit
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2015
Price :
$35
*
At a glance
- Drugs Ivacaftor (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions; Therapeutic Use
- 13 Dec 2015 New trial record